Total Renal Care - Harbor View Dialysis is a medicare approved dialysis facility center in Suffolk, Virginia and it has 16 dialysis stations. It is located in Suffolk City county at 1039 Champions Way, Suffolk, VA, 23435. You can reach out to the office of Total Renal Care - Harbor View Dialysis at (757) 484-2814. This dialysis clinic is managed and/or owned by Davita. Total Renal Care - Harbor View Dialysis has the following ownership type - Profit. It was first certified by medicare in December, 2009. The medicare id for this facility is 492659 and it accepts patients under medicare ESRD program.
| Name | Total Renal Care - Harbor View Dialysis |
|---|---|
| Location | 1039 Champions Way, Suffolk, Virginia |
| No. of Dialysis Stations | 16 |
| Medicare ID | 492659 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1039 Champions Way, Suffolk, Virginia, 23435 | |
| (757) 484-2814 | |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
| NPI Number | 1316186299 |
| Organization Name | Harbour View Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 1039 Champions Way Suffolk, Virginia, 23435 |
| Phone Number | (757) 484-2814 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
| NPI Number | 1609166925 |
| Organization Name | Harbor View Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 3113 Washington Ave Racine, Wisconsin, 53405 |
| Phone Number | (262) 632-0120 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 69% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 15% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 16% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 58% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 35% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 7% | 14% |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 51% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 26% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 23% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 46% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 37% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 17% | 12% |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 75% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 25% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 64% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 12% |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 58 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 28 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 101 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 852 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
| Adult patients getting regular peritoneal dialysis at the center | 27 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 200 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 89 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Total Renal Care - Harbor View Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 129 |
| Hypercalcemia patient months | 1125 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 129 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 18 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 89 |
| Patient months included in arterial venous fistula and catheter summaries | 633 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 66 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 105 |
| Hospitalization Rate in facility | 262.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 406.7 |
| Hospitalization Rate: Lower Confidence Limit | 181.3 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at Total Renal Care - Harbor View Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 29.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 39.8 |
| Readmission Rate: Lower Confidence Limit | 20.3 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Total Renal Care - Harbor View Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .98 (As Expected) |
| SIR: Upper Confidence Limit | 2.04 |
| SIR: Lower Confidence Limit | .4 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Total Renal Care - Harbor View Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 89 |
| Transfusion Rate in facility | 38.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 89.3 |
| Transfusion Rate: Lower Confidence Limit | 18.7 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at Total Renal Care - Harbor View Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 477 |
| Mortality Rate in facility | 17.6 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 23.2 |
| Mortality Rate: Lower Confidence Limit | 13 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago
Artificial Kidney Center - Suffolk Location: 1005 Commercial Lane, Suffolk, Virginia, 23434 Phone: (757) 934-0009 |
Total Renal Care - Harbor View Dialysis Location: 1039 Champions Way, Suffolk, Virginia, 23435 Phone: (757) 484-2814 |
Fresenius Kidney Care North Suffolk Home Location: 5140 River Club Dr., Suffolk, Virginia, 23435 Phone: (757) 483-3050 |
Fresenius Kidney Care North Suffolk Location: 5140 River Club Dr., Suffolk, Virginia, 23435 Phone: (757) 483-2462 |
News Archive
CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.
Papers in leading psychology, economic and science journals that fail to replicate and therefore are less likely to be true are often the most cited papers in academic research, according to a new study by the University of California San Diego's Rady School of Management.
The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.
Genzyme, a Sanofi company, announced today new data from Genzyme's clinical development programs for AUBAGIO (teriflunomide) and LEMTRADATM (alemtuzumab) will be presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13.
› Verified 4 days ago